1. Shi Y; van der Meel R; Chen X; Lammers T.; The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy 2020,10,7921-7924
2. Golombek SK; May JN; Theek B; Tumor targeting via EPR: Strategies to enhance patient responses 2018,130,17-38
3. Rosenblum D.; Joshi N.; Tao W.; Karp J.M.; Peer D.; Progress and challenges towards targeted delivery of cancer therapeutics Internet2018,Vol. 9,1-12 www.nature.com/naturecommunications
4. FDA https://www.fda.gov/regulatory-information/search-fda-guidance documents/considering-whether-fda-regulated-product-involves-application-nanotechnology
5. Yadav A.K.; Mishra P.; Mishra A.K.; Mishra P.; Jain S.; Agrawal G.P.; Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of DOX. Nanomedicine Nanotechnology. Biol Med [Internet].2007,3(4),246-257 https://pubmed.ncbi.nlm.nih.gov/18068091/